UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 155 filers reported holding UNIQURE NV in Q2 2021. The put-call ratio across all filers is 0.17 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $766,246 | -69.1% | 33,800 | -75.3% | 0.11% | +60.9% |
| Q1 2022 | $2,476,000 | -45.7% | 137,000 | -37.7% | 0.07% | -25.8% |
| Q4 2021 | $4,562,000 | -30.0% | 220,000 | +8.1% | 0.09% | -53.0% |
| Q3 2021 | $6,514,000 | +32.2% | 203,500 | +27.2% | 0.20% | +13.1% |
| Q2 2021 | $4,928,000 | -28.7% | 160,000 | -22.0% | 0.18% | +1.2% |
| Q1 2021 | $6,907,000 | +47.1% | 205,000 | +57.7% | 0.17% | +92.2% |
| Q4 2020 | $4,697,000 | -40.7% | 130,000 | -39.5% | 0.09% | -69.3% |
| Q3 2020 | $7,918,000 | +5.9% | 215,000 | +29.5% | 0.29% | -43.3% |
| Q2 2020 | $7,480,000 | +595.8% | 166,000 | +1006.7% | 0.52% | +671.6% |
| Q4 2019 | $1,075,000 | +82.2% | 15,000 | 0.0% | 0.07% | +26.4% |
| Q3 2019 | $590,000 | -67.9% | 15,000 | -36.2% | 0.05% | -73.8% |
| Q2 2019 | $1,837,000 | – | 23,500 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 155,500 | $11,803,000 | 2.66% |
| Aquilo Capital Management, LLC | 901,490 | $16,290,000 | 2.39% |
| Nantahala Capital Management | 2,811,459 | $50,803,000 | 2.25% |
| Privium Fund Management B.V. | 493,229 | $8,913,000 | 1.97% |
| 683 Capital Management, LLC | 1,355,000 | $24,485,000 | 1.31% |
| Henry James International Management Inc. | 125,622 | $2,270,000 | 0.90% |
| Integral Health Asset Management, LLC | 170,000 | $3,072,000 | 0.80% |
| Nantahala Capital Management | 890,000 | $16,082,000 | 0.71% |
| Sonic Fund II, L.P. | 50,000 | $904,000 | 0.51% |
| Voss Capital, LLC | 70,000 | $1,265,000 | 0.40% |